Chemosensory assessment and impact on quality of life in neurosensorial cluster of the post COVID 19 syndrome
Bron
Scientific reports - ISSN 2045-2322-14:1 (2024) p. 1-14
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273 : a randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Bron
International journal of infectious diseases - ISSN 1201-9712-146 (2024) p. 1-11
Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV
Bron
Journal of medical virology - ISSN 0146-6615-96:8 (2024) p. 1-14
The natural history of CVB3 myocarditis in C57BL/6J mice : an extended in-depth characterization
Bron
Cardiovascular pathology - ISSN 1054-8807-72 (2024) p. 1-17
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273 : a randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)
Bron
Vaccine - ISSN 0264-410X-41:48 (2023) p. 7166-7175